""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_component_original"	"response_comp_orig_cnt"	"response_component"	"response_comp_cnt"	"cell_ontology_id"	"proterm_and_extra"	"pro_ontology_id"	"fully_qualified_response_component"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"baseline_time"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"cohort"	"adjuvant"	"route"	"publication_reference"	"publication_year"	"signature_source"	"signature_source_url"	"comments"	"publication_reference_url"	"age_group"	"age_min"	"age_max"	"age_units"	"subm_obs_id"	"uniq_obs_id"	"row_key"	"signature_file"	"target_pathogen_1"	"target_pathogen_2"	"target_pathogen_3"
"subject"	""	""	""	"cell_subset"	""	""	"cell_subset"	""	""	""	""	""	""	""	""	""	""	""	""	""	"vaccine"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	"pathogen"	"pathogen"	"pathogen"
"evidence"	""	""	""	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"file"	""	""	""
"role"	""	""	""	"tissue"	"observed"	"observed"	"cell_biomarker"	"observed"	"observed"	"observed"	"observed"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"background"	"background"	"vaccine"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"background"	"background"	"background"	"reference"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"background"	"observed"	"pathogen"	"pathogen"	"pathogen"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response component (original cell type)"	"response component (original) count"	"response component (cell subset)"	"response component count"	"cell ontology ID"	"cell type PRO and extra terms"	"protein ontology ID"	"all response components in signature"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"baseline time"	"vaccine year"	"exposure material (name)"	"exposure material (VO)"	"additional exposure material"	"comparison"	"cohort"	"adjuvant"	"route"	"publication reference (PMID)"	"publication year"	"signature source figure, table or text section"	"signature source url"	"comments and additional details"	"Nakaya et al. (2016) Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc Natl Acad Sci U S A PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=26755593' target='_blank'>26755593</a>"	"cohort"	"min. age"	"max. age"	"age units"	"ID of observation within its own submission"	"Uniq ID of observation within its submission type"	"row key"	"signature response component (cell types) file"	"target pathogen 1"	"target pathogen 2"	"target pathogen 3"
""	"hipc_ctf_26755593_3"	"2016.02"	"hipc_ctf_26755593_3"	"peripheral blood mononuclear cell"	"intereferon-gamma-positive, tumor-necrosis-factor-alfa-positive, interleukin-2-positive, effector memory CD4-positive, alpha-beta T cell"	"2"	"effector memory CD4-positive, alpha-beta T cell"	"2"	"CL_0000905"	"& TNF-a, IL-2+"	"PR:000000134, PR:000001379"	"effector memory CD4-positive, alpha-beta T cell & TNF-a, IL-2+"	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (second dose)"	"2012"	"Fluad"	"VO_0004281"	""	"28d (postboost) vs 0d (pre-imm)"	"children (14-27mo)"	""	""	"26755593"	"2016"	"Fig 2A"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/' target='_blank'>figure/fig02</a>"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/"	"children"	"14"	"27"	"months"	"3"	"28"	"26755593_3_28"	"hipc_ctf_sig_26755593_3.txt"	"influenza A virus (A/California/7/2009(H1N1))"	"influenza A virus (A/Victoria/361/2011(H3N2))"	"influenza B virus (B/Wisconsin/01/2010)"
""	"hipc_ctf_26755593_3"	"2016.02"	"hipc_ctf_26755593_3"	"peripheral blood mononuclear cell"	"intereferon-gamma-negative, tumor-necrosis-factor-alfa-positive, interleukin-2-positive, effector memory CD4-positive, alpha-beta T cell"	"2"	"effector memory CD4-positive, alpha-beta T cell"	"2"	"CL_0000905"	"& IFNG-, TNF-a+, IL-2+"	"PR:000000017, PR:000000134, PR:000001379"	"effector memory CD4-positive, alpha-beta T cell & IFNG-, TNF-a+, IL-2+"	"cell type frequency"	"up"	"none"	"28"	"Days"	"time of vaccination (second dose)"	"2012"	"Fluad"	"VO_0004281"	""	"28d (postboost) vs 0d (pre-imm)"	"children (14-27mo)"	""	""	"26755593"	"2016"	"Fig 2A"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/figure/fig02/' target='_blank'>figure/fig02</a>"	""	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763735/"	"children"	"14"	"27"	"months"	"3"	"28"	"26755593_3_28"	"hipc_ctf_sig_26755593_3.txt"	"influenza A virus (A/California/7/2009(H1N1))"	"influenza A virus (A/Victoria/361/2011(H3N2))"	"influenza B virus (B/Wisconsin/01/2010)"
